Present Title & Affiliation Primary Appointment Associate Vice President for Translational Integration, Office of Chief Scientific Officer, The University of Texas MD Anderson Cancer Center, Houston, TX TRACTION Medical Director, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Deputy Chair for Translational Research, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Dual/Joint/Adjunct Appointment Dr
GLP-1 Agonists and Pancreatitis Risk: Reassessing an Old Concern with New Evidence A Renewed Look at an Old Controversy Ever since GLP-1 receptor agonists (GLP-1 RAs) entered clinical practice for diabetes and obesity, their metabolic benefits have been undeniable
And GLP-1s can also produce plenty of side effects, which, in combination with their high costs and shortages, prompts most patients to stop taking the drugs within the same year
[DOI] [PubMed] [Google Scholar] 14.Franco RSO
